Who is sponsoring NCT03612076?

NCT03612076 is sponsored by Hospices Civils de Lyon.

What drugs are being tested in NCT03612076?

Interventions in NCT03612076: Global cost of management of PJI.

What condition does NCT03612076 study?

NCT03612076 studies Prosthetic Joint Infection.

Is NCT03612076 still recruiting?

NCT03612076 is currently completed. Last updated 16 December 2020.

Last reviewed 2020-12-16 · How we verify

NCT03612076

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cost Of Failure Following Reimplantation After a 2-Stage Exchange Strategy For Hip Or Knee Prosthetic Joint Infection

Completed Last updated 16 December 2020

What this trial tests

trial testing Global cost of management of PJI in Prosthetic Joint Infection in 115 participants. Completed in 1 July 2018.

Timeline

1 December 2016

Primary endpoint
1 July 2018

1 July 2018

Quick facts

Lead sponsor	Hospices Civils de Lyon
Status	Completed
Study type	OBSERVATIONAL
Enrollment	115
Start date	1 December 2016
Primary completion	1 July 2018
Estimated completion	1 July 2018
Sites	1 location across France

Drugs / interventions tested

Global cost of management of PJI

Conditions studied

Prosthetic Joint Infection — all drugs for Prosthetic Joint Infection →

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

Adults 18 to 100, any sex, with Prosthetic Joint Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study concerns patients having had an infection on their prosthesis (hip, knee,..) and for whom a 2-step exchange of prosthesis has been done. A 2-step exchange consists in explantation of the prosthesis and implementation of a spacer at the first stage, and reimplantation of a new prosthesis in a second stage. Patients with late prosthetic joint infection are at risk for superinfection at the time of reimplantation. The aim of this study is to determine the global cost of management of prosthetic joint infection.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Economic Study of 2-Stage Exchange in Patients With Knee or Hip Prosthetic Joint Infection Managed in a Referral Center in France: Time to Use Innovative(s) Intervention(s) at the Time of Reimplantation to Reduce the Risk of Superinfection.
Serrier H, Julien C, Batailler C, Mabrut E, et al · · 2021 · cited 11× · PMID 34041248 · DOI 10.3389/fmed.2021.552669

Verify or expand the search:

Other recruiting trials for Prosthetic Joint Infection

Currently open trials in the same condition.

NCT07107685 — Prosthetic Joint Infection : Lessons From Deceased Patients in Critical Care. · recruiting
NCT06627842 — OsteoArticular Sepsis in Intensive Care unitS · recruiting
NCT04650607 — Phage Safety Cohort Study · recruiting
NCT04858217 — Periprosthetic Joint Infections: Diagnostic Accuracy and Cost-effectiveness Analysis of Serum and Synovial Markers · recruiting
NCT04724603 — Phage Safety Retrospective Cohort Study · recruiting

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03612076 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
Last refreshed: 16 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03612076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing